MedWatch

Analyst says GN Hearing's acquisition will build bridges and bring in customers

Acquiring US-based Lively should be seen a step in GN Hearing's preparations for the upcoming over-the-counter sales channel in the US, says Senior Equity Analyst at Sydbank Søren Løntoft Hansen.

Photo: GN Hearing / PR

It makes sense for GN Hearing to take over US-based hearing healthcare firm Lively, opines Senior Equity Analyst at Sydbank Søren Løntoft Hansen following the announced acquisition by GN Hearing on Tuesday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs